Pharmacoeconomic analysis of cost-benefit in evaluating the effectiveness of treatment for epilepsy in adults

• Main Authors: P. N. Vlasov, N. V. Orekhova, M. V. Leonova
• Format: Article
• Language: Russian
• Published: IMA-PRESS LLC 2010-06-01
• Series: Nevrologiâ, Nejropsihiatriâ, Psihosomatika
• Subjects: adult epilepsy; pharmacoeconomic analysis; cost-benefit; antiepileptics
• Online Access: https://nnp.ima-press.net/nnp/article/view/44

The investigation evaluated the clinicoeconomic benefits of epilepsy therapy performed by a district neurologist versus an epileptologist in the outpatient setting. The index «cost-benefit» was calculated for different types of epileptic seizures in employed and unemployed patients before and after therapy optimization. Even if there was a considerable increase in direct costs after correction of antiepileptic therapy, the cost of patient management was shown to decrease by 2-3 times on average irrespective of the type of a seizure.